Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Durogesic D-TRANS for Pain in Lung Cancer
NCT01060137Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- May 2006
- Primary completion
- May 2007
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of Durogesic D-TRANS in cancer pain, sponsored by Janssen Pharmaceutical. Started May 2006; status: completed.
02
Drugs
Durogesic D-TRANS
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT01060137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01060137.